STOCK TITAN

[8-K] MARRIOTT VACATIONS WORLDWIDE CORPORATION Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Gilead Sciences (GILD) filed an 8-K to disclose that its Board adopted Amended & Restated Bylaws effective 30 Jul 2025.

  • Advance-notice tightened: expanded disclosure on nominating shareholders, concert parties and solicitation plans; nominees capped at the number of seats up for election.
  • Universal proxy compliance: bylaws now mandate adherence to SEC Rule 14a-19 and reserve the white proxy card exclusively for the company.
  • DGCL alignment: updates on adjournment notices and stockholder-list availability reflect recent Delaware law changes; emergency-condition provisions added under DGCL §110.
  • Board mechanics refined: clarifies majority-vote standard for director elections, vacancy filling, and procedures for Board and committee meetings.

No financial figures or operational developments were reported; the event is purely a corporate-governance revision. Full text appears in Exhibit 3.1.

Gilead Sciences (GILD) ha depositato un modulo 8-K per comunicare che il suo Consiglio di Amministrazione ha adottato il Regolamento Amministrativo Modificato e Ristabilito, efficace dal 30 luglio 2025.

  • Avviso anticipato più restrittivo: ampliata la divulgazione riguardo agli azionisti che propongono candidature, parti concordate e piani di sollecitazione; il numero di candidati è limitato al numero di seggi in elezione.
  • Conformità al proxy universale: il regolamento ora richiede l’osservanza della Regola SEC 14a-19 e riserva la scheda proxy bianca esclusivamente all’azienda.
  • Allineamento al DGCL: aggiornamenti sulle comunicazioni di rinvio e sulla disponibilità dell’elenco degli azionisti riflettono le recenti modifiche della legge del Delaware; sono state aggiunte disposizioni per condizioni di emergenza ai sensi del DGCL §110.
  • Raffinamento delle procedure del Consiglio: chiarisce il criterio della maggioranza per l’elezione dei direttori, la copertura delle vacanze e le procedure per le riunioni del Consiglio e delle commissioni.

Non sono stati riportati dati finanziari o sviluppi operativi; si tratta esclusivamente di una revisione della governance aziendale. Il testo completo è disponibile nell’Exhibit 3.1.

Gilead Sciences (GILD) presentó un formulario 8-K para informar que su Junta Directiva adoptó los Estatutos Modificados y Reexpresados, vigentes a partir del 30 de julio de 2025.

  • Notificación anticipada más estricta: se amplió la divulgación sobre accionistas nominadores, partes concertadas y planes de solicitud; los nominados están limitados al número de puestos en elección.
  • Cumplimiento del poder universal: los estatutos ahora exigen adherirse a la regla SEC 14a-19 y reservan la tarjeta proxy blanca exclusivamente para la compañía.
  • Alineación con DGCL: las actualizaciones sobre avisos de aplazamiento y disponibilidad de la lista de accionistas reflejan los cambios recientes en la ley de Delaware; se añadieron disposiciones para condiciones de emergencia bajo el DGCL §110.
  • Mejoras en la mecánica del Consejo: aclara el estándar de voto mayoritario para elecciones de directores, llenado de vacantes y procedimientos para reuniones del Consejo y comités.

No se reportaron cifras financieras ni desarrollos operativos; el evento es únicamente una revisión de la gobernanza corporativa. El texto completo aparece en el Anexo 3.1.

길리어드 사이언스(Gilead Sciences, GILD)는 8-K 보고서를 제출하여 이사회가 2025년 7월 30일부터 발효되는 수정 및 재정비된 정관을 채택했음을 공개했습니다.

  • 사전 통지 강화: 주주 추천자, 공동행동자 및 모집 계획에 대한 공개 확대; 후보자는 선출 예정 이사회 의석 수로 제한.
  • 보편적 위임장 준수: 정관은 이제 SEC 규칙 14a-19 준수를 의무화하며, 백지 위임장은 회사에만 독점적으로 사용됩니다.
  • 델라웨어 기업법(DGCL) 정합성: 연기 통지 및 주주 명부 제공에 관한 업데이트는 델라웨어 법률 변경을 반영하며, DGCL §110에 따른 비상 상황 조항이 추가됨.
  • 이사회 운영 절차 개선: 이사 선출을 위한 과반수 투표 기준, 공석 보충 및 이사회 및 위원회 회의 절차를 명확히 함.

재무 수치나 운영 관련 발전 사항은 보고되지 않았으며, 이번 조치는 순수한 기업 지배구조 개정입니다. 전체 내용은 부록 3.1에 게재되어 있습니다.

Gilead Sciences (GILD) a déposé un formulaire 8-K pour annoncer que son Conseil d'administration a adopté les Statuts modifiés et reformulés, effectifs à compter du 30 juillet 2025.

  • Notification anticipée renforcée : divulgation élargie concernant les actionnaires proposant des candidats, les parties concertées et les plans de sollicitation ; le nombre de candidats est limité au nombre de sièges à pourvoir.
  • Conformité au proxy universel : les statuts exigent désormais le respect de la règle SEC 14a-19 et réservent la carte proxy blanche exclusivement à la société.
  • Alignement avec le DGCL : les mises à jour sur les avis de report et la disponibilité de la liste des actionnaires reflètent les récentes modifications du droit du Delaware ; des dispositions relatives aux situations d'urgence ont été ajoutées conformément au DGCL §110.
  • Affinement des procédures du Conseil : clarifie la norme de vote à la majorité pour l'élection des administrateurs, le comblement des postes vacants et les procédures des réunions du Conseil et des comités.

Aucun chiffre financier ni développement opérationnel n'a été rapporté ; l'événement constitue uniquement une révision de la gouvernance d'entreprise. Le texte complet figure en Annexe 3.1.

Gilead Sciences (GILD) hat eine 8-K-Meldung eingereicht, um bekanntzugeben, dass der Vorstand die geänderte und neu gefasste Satzung mit Wirkung zum 30. Juli 2025 angenommen hat.

  • Strengere Vorankündigung: erweiterte Offenlegung zu nominierenden Aktionären, abgestimmten Parteien und Werbeplänen; Kandidatenzahl ist auf die Anzahl der zu wählenden Sitze begrenzt.
  • Einheitliche Proxy-Konformität: die Satzung verlangt nun die Einhaltung der SEC-Regel 14a-19 und reserviert die weiße Stimmkarte ausschließlich für das Unternehmen.
  • DGCL-Anpassung: Aktualisierungen zu Vertagungsmitteilungen und Verfügbarkeit der Aktionärsliste spiegeln die jüngsten Änderungen im Delaware-Recht wider; Notfallbestimmungen gemäß DGCL §110 wurden hinzugefügt.
  • Verfeinerung der Vorstandsmethoden: klärt die Mehrheitswahlregel für Direktorenwahlen, die Nachbesetzung von Vakanzstellen und die Verfahren für Vorstandssitzungen und Ausschüsse.

Es wurden keine finanziellen Zahlen oder operative Entwicklungen gemeldet; das Ereignis ist ausschließlich eine Überarbeitung der Unternehmensführung. Der vollständige Text ist in Anlage 3.1 enthalten.

Positive
  • Compliance alignment with SEC universal proxy rules and updated Delaware law reduces legal risk and potential procedural challenges.
  • Clarified board procedures may enhance governance efficiency during emergencies and director vacancies.
Negative
  • Increased barriers for shareholder nominations and reservation of the white proxy card may be perceived as anti-activist, raising governance-entrenchment concerns.

Insights

TL;DR: Bylaw changes tighten nomination rules, meet universal proxy regs, and fortify Board control—moderately alters shareholder dynamics.

The Board’s revisions modernize the bylaws in line with SEC and DGCL changes while subtly reinforcing management’s position. Mandatory compliance with Rule 14a-19 is legally required, but reserving the white card and increasing disclosure burdens raise the hurdle for activist campaigns. Emergency provisions and clearer vacancy-filling language improve continuity. Overall, the amendments are standard among large-cap issuers and unlikely to move valuation, yet they incrementally shift leverage toward the incumbent Board.

TL;DR: Governance housekeeping; no cash-flow impact, but slightly activist-defensive. Neutral to fundamentals.

From a portfolio perspective the filing lacks financial ramifications—no guidance, no capital allocation changes. The higher disclosure threshold for nominations may deter short-term activist noise, arguably providing management stability to focus on R&D execution. However, it could be viewed as entrenchment, a minor ESG concern. Absent earnings data, I rate the event neutral for stock valuation.

Gilead Sciences (GILD) ha depositato un modulo 8-K per comunicare che il suo Consiglio di Amministrazione ha adottato il Regolamento Amministrativo Modificato e Ristabilito, efficace dal 30 luglio 2025.

  • Avviso anticipato più restrittivo: ampliata la divulgazione riguardo agli azionisti che propongono candidature, parti concordate e piani di sollecitazione; il numero di candidati è limitato al numero di seggi in elezione.
  • Conformità al proxy universale: il regolamento ora richiede l’osservanza della Regola SEC 14a-19 e riserva la scheda proxy bianca esclusivamente all’azienda.
  • Allineamento al DGCL: aggiornamenti sulle comunicazioni di rinvio e sulla disponibilità dell’elenco degli azionisti riflettono le recenti modifiche della legge del Delaware; sono state aggiunte disposizioni per condizioni di emergenza ai sensi del DGCL §110.
  • Raffinamento delle procedure del Consiglio: chiarisce il criterio della maggioranza per l’elezione dei direttori, la copertura delle vacanze e le procedure per le riunioni del Consiglio e delle commissioni.

Non sono stati riportati dati finanziari o sviluppi operativi; si tratta esclusivamente di una revisione della governance aziendale. Il testo completo è disponibile nell’Exhibit 3.1.

Gilead Sciences (GILD) presentó un formulario 8-K para informar que su Junta Directiva adoptó los Estatutos Modificados y Reexpresados, vigentes a partir del 30 de julio de 2025.

  • Notificación anticipada más estricta: se amplió la divulgación sobre accionistas nominadores, partes concertadas y planes de solicitud; los nominados están limitados al número de puestos en elección.
  • Cumplimiento del poder universal: los estatutos ahora exigen adherirse a la regla SEC 14a-19 y reservan la tarjeta proxy blanca exclusivamente para la compañía.
  • Alineación con DGCL: las actualizaciones sobre avisos de aplazamiento y disponibilidad de la lista de accionistas reflejan los cambios recientes en la ley de Delaware; se añadieron disposiciones para condiciones de emergencia bajo el DGCL §110.
  • Mejoras en la mecánica del Consejo: aclara el estándar de voto mayoritario para elecciones de directores, llenado de vacantes y procedimientos para reuniones del Consejo y comités.

No se reportaron cifras financieras ni desarrollos operativos; el evento es únicamente una revisión de la gobernanza corporativa. El texto completo aparece en el Anexo 3.1.

길리어드 사이언스(Gilead Sciences, GILD)는 8-K 보고서를 제출하여 이사회가 2025년 7월 30일부터 발효되는 수정 및 재정비된 정관을 채택했음을 공개했습니다.

  • 사전 통지 강화: 주주 추천자, 공동행동자 및 모집 계획에 대한 공개 확대; 후보자는 선출 예정 이사회 의석 수로 제한.
  • 보편적 위임장 준수: 정관은 이제 SEC 규칙 14a-19 준수를 의무화하며, 백지 위임장은 회사에만 독점적으로 사용됩니다.
  • 델라웨어 기업법(DGCL) 정합성: 연기 통지 및 주주 명부 제공에 관한 업데이트는 델라웨어 법률 변경을 반영하며, DGCL §110에 따른 비상 상황 조항이 추가됨.
  • 이사회 운영 절차 개선: 이사 선출을 위한 과반수 투표 기준, 공석 보충 및 이사회 및 위원회 회의 절차를 명확히 함.

재무 수치나 운영 관련 발전 사항은 보고되지 않았으며, 이번 조치는 순수한 기업 지배구조 개정입니다. 전체 내용은 부록 3.1에 게재되어 있습니다.

Gilead Sciences (GILD) a déposé un formulaire 8-K pour annoncer que son Conseil d'administration a adopté les Statuts modifiés et reformulés, effectifs à compter du 30 juillet 2025.

  • Notification anticipée renforcée : divulgation élargie concernant les actionnaires proposant des candidats, les parties concertées et les plans de sollicitation ; le nombre de candidats est limité au nombre de sièges à pourvoir.
  • Conformité au proxy universel : les statuts exigent désormais le respect de la règle SEC 14a-19 et réservent la carte proxy blanche exclusivement à la société.
  • Alignement avec le DGCL : les mises à jour sur les avis de report et la disponibilité de la liste des actionnaires reflètent les récentes modifications du droit du Delaware ; des dispositions relatives aux situations d'urgence ont été ajoutées conformément au DGCL §110.
  • Affinement des procédures du Conseil : clarifie la norme de vote à la majorité pour l'élection des administrateurs, le comblement des postes vacants et les procédures des réunions du Conseil et des comités.

Aucun chiffre financier ni développement opérationnel n'a été rapporté ; l'événement constitue uniquement une révision de la gouvernance d'entreprise. Le texte complet figure en Annexe 3.1.

Gilead Sciences (GILD) hat eine 8-K-Meldung eingereicht, um bekanntzugeben, dass der Vorstand die geänderte und neu gefasste Satzung mit Wirkung zum 30. Juli 2025 angenommen hat.

  • Strengere Vorankündigung: erweiterte Offenlegung zu nominierenden Aktionären, abgestimmten Parteien und Werbeplänen; Kandidatenzahl ist auf die Anzahl der zu wählenden Sitze begrenzt.
  • Einheitliche Proxy-Konformität: die Satzung verlangt nun die Einhaltung der SEC-Regel 14a-19 und reserviert die weiße Stimmkarte ausschließlich für das Unternehmen.
  • DGCL-Anpassung: Aktualisierungen zu Vertagungsmitteilungen und Verfügbarkeit der Aktionärsliste spiegeln die jüngsten Änderungen im Delaware-Recht wider; Notfallbestimmungen gemäß DGCL §110 wurden hinzugefügt.
  • Verfeinerung der Vorstandsmethoden: klärt die Mehrheitswahlregel für Direktorenwahlen, die Nachbesetzung von Vakanzstellen und die Verfahren für Vorstandssitzungen und Ausschüsse.

Es wurden keine finanziellen Zahlen oder operative Entwicklungen gemeldet; das Ereignis ist ausschließlich eine Überarbeitung der Unternehmensführung. Der vollständige Text ist in Anlage 3.1 enthalten.

0001524358false00015243582025-08-042025-08-04

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
FORM 8-K
_________________________
Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 4, 2025
_________________________
Marriott Vacations Worldwide Corporation
(Exact name of registrant as specified in its charter)
 _________________________
Delaware 001-35219 45-2598330
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
7812 Palm Parkway
Orlando,FL
32836
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code (407) 206-6000
N/A
(Former name or former address, if changed since last report)
_________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 Par ValueVACNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02 Results of Operations and Financial Condition
On August 4, 2025, Marriott Vacations Worldwide Corporation (the “Company”) issued a press release reporting financial results for the quarter ended June 30, 2025. A copy of the press release is attached as Exhibit 99.1 hereto and incorporated herein by reference.
As provided in General Instruction B.2 of Form 8-K, the information contained in Item 2.02 of this Current Report on Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act of 1934, as amended, nor shall any such information be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended.
Item 7.01 Regulation FD Disclosure
On August 5, 2025, the Company intends to post a new investor presentation to the Investor Relations – Events and Presentations section of the Company’s website, www.marriottvacationsworldwide.com. The Company’s investor presentation is expected to contain information that may be deemed material to investors. The Company uses its website to disseminate updates to its investor presentation and does not intend to file or furnish a Current Report on Form 8-K to alert investors each time the presentation is updated.
The Company routinely posts important information, including news releases, announcements and other statements about its business and results of operations, that may be deemed material to investors on the Investor Relations section of the Company’s website, www.marriottvacationsworldwide.com. The Company uses its website as a means of disclosing material, nonpublic information and for complying with the Company’s disclosure obligations under Regulation FD. Investors should monitor the Investor Relations section of the Company’s website in addition to following the Company’s press releases, filings with the SEC, public conference calls and webcasts.
Item 9.01 Financial Statements and Exhibits.
(d) The following exhibits are being furnished herewith: 
Exhibit NumberDescription
99.1
Press release reporting financial results for the quarter ended June 30, 2025
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
MARRIOTT VACATIONS WORLDWIDE CORPORATION
(Registrant)
Dated: August 4, 2025By:/s/ Jason P. Marino
Name:Jason P. Marino
Title:Executive Vice President and Chief Financial Officer

1

FAQ

What did Gilead Sciences (GILD) change in its bylaws?

The Board adopted Amended & Restated Bylaws tightening advance-notice rules, requiring universal proxy compliance, and aligning with updated Delaware law.

When did the new bylaws of GILD take effect?

July 30, 2025, the date the Board approved the amendments.

How do the changes affect shareholder nominations at Gilead?

Shareholders must provide expanded disclosures, may not exceed the number of board seats up for election, and must comply with Rule 14a-19.

Does the 8-K contain any financial results for GILD?

No, the filing is limited to corporate governance changes; no revenue, EPS or guidance were provided.

Where can investors read the full text of the new bylaws?

The complete document is filed as Exhibit 3.1 to the 8-K and is available on the SEC’s EDGAR system.
Marriott Vacations Worldwide C

NYSE:VAC

VAC Rankings

VAC Latest News

VAC Latest SEC Filings

VAC Stock Data

2.52B
31.53M
8.65%
89.78%
6.5%
Resorts & Casinos
Real Estate Agents & Managers (for Others)
Link
United States
ORLANDO